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A B S T R A C T
Sea lice are a major challenge for the Norwegian aquaculture, and to cope with sea lice infections, several
physical, biological and chemical treatments are applied. This study presents data on the use of anti-sea lice
agents for Norwegian farmed fish from 1992 to 2017, and results from the surveillance of residues of such agents
in samples collected from 2002 to 2017. In the period 2002–2007 the use of anti-sea lice agents included
emamectin, cypermethrin and deltamethrin. Azamethiphos and flubenzurons were introduced in 2008 and
2009, respectively. In the ongoing surveillance of Norwegian farmed fish, more than 3000 pooled samples have
been examined for residues of anti-sea lice agents in the period from 2002 to 2017. Residues were detected in 3%
of the samples. Emamectin was detected in 5.0% of the samples analyzed for emamectin, while cypermethrin
was detected in 2.1% of the samples analyzed for cypermethrin. Furthermore, residues of diflubenzuron and
teflubenzuron were detected in 1.2 and 0.1% of the samples analyzed for these compounds, respectively. None of
the other anti-sea lice agents were detected. No measurements were above the respective maximum residue limit
(MRL) set by the EU.
1. Introduction
Sea lice (Lepeophtheirus salmonis) are ectoparasitic copepods natu-
rally occurring in the sea. Their lifecycle involves eight stages (Hamre
et al., 2013). Each stage is separated by a moult (Johnson and Albright,
1991). During the two first naupliar stages and the following infectious
copepodid stage, the sea lice are planktonic: they cannot swim direc-
tionally against the current but are able to adjust their vertical depth.
For the two next stages, the chalimus stages, the lice are attached to the
fish. Thereafter follows two pre-adult stages and one adult stage, where
the lice are able to move around on the surface of the fish (Hamre et al.,
2013). During the last decade, sea lice have become one of the main
challenges in the Norwegian fish farming industry. Sea lice feed on the
mucus, skin and blood of the hosts, and their impact varies from mild
skin damage to stress-induced mortality of individual fish. Lice-infested
fish can exhibit reduced appetite, growth rate and food-conversion ef-
ficiency (Pike and Wadsworth, 2000). Sea lice also affect wild salmo-
nids, the extent of the impact of aquaculture on sea lice infestation on
wild fish is fiercely debated in countries where wild salmonids and
farmed salmonids coexist (Krkosek, 2008).
In recent years, several strategies involving physical, biological and
chemical approaches have been developed to cope with sea lice in
salmon farms. Although the use of cleaner fish, that prey on sea lice
(Imsland et al., 2014), and numerous physical treatments (Powell et al.,
2015; Stien et al., 2016) has increased, chemical treatment is still an
important tool to control the level of infestation. Anti-sea lice agents
can be administered by bath treatment or as additives in the feed
(Urbina et al., 2019). Since 1992, the chemicals used as bath treatment
in Norwegian aquaculture comprise the organophosphates; me-
trifonate, azamethiphos and dichlorvos, the pyrethroids; pyrethrins,
cypermethrin and deltamethrin, and hydrogen peroxide. The aver-
mectin; emamectin, and the flubenzurons; teflubenzuron and di-
flubenzuron have been used as additives in the feed.
The anti-sea lice agents differ in their mode of action and efficacy.
The organophosphates are acetylcholinesterase inhibitors, they are ef-
fective against adult and pre-adult stages of sea lice (Roth et al., 1996).
The pyrethroids disrupt the sodium channel function, and are effective
in both chalimus, preadult and adult stages of sea lice (Burka et al.,
1997). Hydrogen peroxide is a strong oxidizing agent and cause sea lice
to separate from its host (Thomassen, 1993), and is most effective
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against lice in their mobile life stages (Treasurer and Grant, 1997).
Emamectin blocks nerve transmission, causing paralysis and death of
the sea lice (Arena et al., 1995; Vassilatis et al., 1997). Emamectin has a
high efficacy against all parasitic stages of sea lice on farmed salmon,
and treatment also prevents recruitment of new lice for approximately
10 weeks (Stone et al., 2000). Flubenzurons inhibit chitin synthesis, and
their efficiency are therefore restricted to the moulting stages of sea
lice, and no effect is thus perceived on adult lice that has already
formed their final exoskeleton (Branson et al., 2000; Burka et al., 1997).
Norway is one of the main producers and exporters of marine
farmed fish (FAO, 2016). In 2017, approximately 1.3 mill tons of
farmed fish, mainly Atlantic salmon (Salmo salar) were produced. The
scope of the present study is to delineate the use of anti-sea lice agents,
and assess their possible impact on food safety. Prior to market au-
thorization in Norway any veterinary drug requires approval by the
European Commission (EU 37/2010) and The Norwegian Medicines
Agency (NoMA). Drugs intended for therapeutic use in farmed fish re-
quire prescriptions from veterinarians or fish health biologists. From
1989, it has been mandatory for both prescribing veterinarians and feed
mills to send a copy of each prescription, first to the Norwegian Gov-
ernment Fish Inspection and Quality Control Service (NFCS) and
thereafter from 2004 to the Norwegian Food Safety Authority (NFSA).
Further, to ensure food safety, a systematic surveillance system is ob-
liged under the current EU regulations (European Commision, 1996).
The aim of this study is to describe the amount of anti-sea lice
agents used in Norwegian aquaculture and using data on residues from
the Norwegian monitoring program on farmed fish, to describe the
possible implications in regards to food safety.
2. Materials and methods
2.1. The use of veterinary drugs in Norway
Statistics on drugs sold for use in Norwegian farmed fish were ob-
tained from the Norwegian Institute of Public Health (NIPH). To cal-
culate the annually treated biomass, the amount of active substance was
adjusted using the dosage described in the package leaflets (Table 1).
The treatment ratio was calculated from the relation between the an-
nually treated biomass and the biomass slaughtered (Directorate of
Fisheries, 2019).
2.2. Sampling and sample preparation
Data was obtained from the ongoing surveillance of Norwegian
farmed fish according to council directive 96/23/EC, on measures to
monitor certain substances and residues thereof in live animals and
animal products (European Commision, 1996). The total number of
samples collected in the surveillance is dependent on the production
volume (European Commision, 1996). From 2002 to 2017 the pro-
duction of Norwegian farmed salmonids increased from 546,000 t to
1,285,000 t, leading to an increase in the total number of samples to be
monitored. The number of samples examined for each veterinary drug
is set by the Norwegian Food Safety Authority (NFSA). The priorities
are mainly based on the prescription of pharmaceuticals used in the
industry. The samples were collected annually from 2002 to 2017,
throughout the season in all fish-producing regions in Norway. The
samples were collected at processing plants by inspectors from the Di-
rectorate of Fisheries until 2004, and by inspectors from the NFSA from
2005. The samples include salmonid species in Norwegian aquaculture,
primarily Atlantic salmon (Salmo salar) (n = 2993), and to a lesser
extent rainbow trout (Oncorhynchus mykiss) (n = 219) and Arctic char
(Salvelinus alpinus) (n = 2). Standardised muscle samples, the Norwe-
gian Quality Cut (NQC) (Johnsen et al., 2011), were collected from five
fish from the same net pen, and frozen (−20 °C) in sealed plastic bags
before sent in a frozen state to The Institute of Marine Research (IMR).
Upon arrival at IMR, composite samples were prepared by pooling
equal amounts of muscle from five individual fish. The samples were
stored at −20 °C prior to analysis. For all samples, a back-up sample
was stored. From 2014, the skin was included in the back-up sample.
The MRL for fish is set for muscle and skin in natural proportions
(European Commision, 2010), where the proportions between muscle
and skin is 9:1. Therefore, any detection of anti-sea lice agents in the
muscle sample led to reanalysis of the back-up sample where skin was
included. For these samples the reported results are from muscle and
skin.
2.3. Analyses
The samples were analyzed for the anti-sea lice agents emamectin,
diflubenzuron, teflubenzuron, cypermethrin, deltamethrin, azamethi-
phos or/and dichlorvos. From 2002, both sample preparation and in-
strumentation have improved, and the methods used have been
amended. Hence, the limit of quantification has been modified for
several of the methods (Supplement table 2). In addition, there has been
a development from single analyte methods, towards including several
analytes in the same method, giving more results for each sample. A
blank sample and control sample have been included together with
standards for all methods.
2.3.1. Analysis of emamectin
From 2004 to 2014, samples analyzed for emamectin were prepared
as described in Skilbrei et al. (2008) and determined by LC-MS (Hamre
et al., 2011). From 2015, emamectin was analyzed by two methods.
Most of the samples were analyzed by using emamectin-d3 as internal
standard, before acetonitrile was used for extraction. The extract was
evaporated and resolved in a mix of methanol and water. Emamectin
was determined by LC-MS/MS using electrospray ionization (ESI) in a
positive MRM mode. For a part of the samples, a mix of acetonitrile and
water were used for extraction. Petroleum ether was used to remove fat,
and the samples were analyzed by LC-MS/MS using electrospray ioni-
zation (ESI) in a positive MRM mode.
2.3.2. Analyses of teflubenzuron and diflubenzuron
From 2002 to 2014, diflubenzuron was analyzed by LC-MS (Hamre
et al., 2013). Teflubenzuron was determined by a similar method as
diflubenzuron as described earlier (Samuelsen et al., 2014). From 2015,
diflubenzuron and teflubenzuron were analyzed by two methods. Most
Table 1
Biomass fish treated per kilo drug.
Chemical Dosage bath
treatment




















*daily for 14 days
**daily for 7 days
The dosage used in the calculations are specifies for each anti-sea lice drug.
For bath treatments it is estimated that each m3 contains 50 kg salmonids.
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of the samples were analyzed by a method using diflubenzuron-d4 as
internal standard for both diflubenzuron and teflubenzuron. The flu-
benzurons were extracted by acetone, and the extract were purified by
solid phase extraction (SPE) before analysis by LC-MS/MS using ESI in a
negative MRM mode (Olsvik et al., 2015). For a part of the samples, a
mix of acetonitrile and water were used for extraction. Petroleum ether
was used to remove fat, and the samples were analyzed by LC-MS/MS
using electrospray ionization (ESI) in a positive MRM mode.
2.3.3. Analyses of cypermethrin and deltamethrin
From 2002 to 2014, cypermethrin and deltamethrin were extracted
by acetone. A liquid-liquid extraction was performed to purify the ex-
tract. Additional sample clean-up was performed by gel permeation
chromatography (GPC) followed by solid phase extraction (SPE). The
sample was analyzed by GC–MS with electron impact (EI) ionization.
From 2015, the pyrethrins were soxhlet extracted using methyl-tert-
butyl ether. Thereafter sample clean-up was performed by gel per-
meation chromatography (GPC) followed by a clean-up process using
primary secondary amine. The sample was analyzed by analyzed by
GC–MS/MS.
2.3.4. Analyses of azamethiphos and dichlorvos
From 2004 to 2006, azamethiphos was extracted by ethyl acetate. A
liquid-liquid extraction was used to purify the extract. Additional
sample clean-up was performed by SPE. The sample was analyzed by
HPLC-FLD. In the same period, dichlorvos was extracted by a mix of
acetone and cyclohexane. Sample clean-up was performed by SPE. The
sample was analyzed by GC–MS with EI ionization. From 2010 to 2014,
azamethiphos and dichlorvos were extracted by acetone. The extract
was purified by GPC and analyzed by GC-FLD. From 2015, azamethi-
phos and dichlorvos were extracted by a mix of acetonitrile and water,
petroleum ether was used for samples clean-up, and the samples were
analyzed by LC-MS/MS using electrospray ionization (ESI) in a positive
MRM mode.
3. Results
3.1. Use of anti-sea lice agents in Norwegian farmed fish
Anti-sea lice agents used in Norway in the period 1992 to 2017
include metrifonate, pyrethrins, dichlorvos, azamethiphos, cyperme-
thrin, deltamethrin, emamectin, teflubenzuron, diflubenzuron and hy-
drogen peroxide (Table 2). In 1992, only metrifonate and dichlorvos
were used against sea lice, however, the following years several other
compounds were included in the treatments. From 2002 to 2007 the
drugs used comprised of cypermethrin, deltamethrin and emamectin. In
2008, azamethiphos was also used. From 2009 and onwards, treatments
also included use of hydrogen peroxide, teflubenzuron and di-
flubenzuron. Until 1998, the total amount of anti-sea lice agents used
(in kilograms) were high, ranging between 2000 and 700,000 kg
(Table 2). Between the years 1999 to 2008, the use of anti-sea lice
agents was lower, ranging from 98 to 329 kg active compound. From
2008 to 2009 the amount used increased from 218 kg to 314,000 kg
active compound and continued to increase to 43 million kg active
compound in 2015. Thereafter, the amount decreased to 9 million kg in
2017.
The estimated biomass fish (tonnes) treated with anti-sea lice agents
in the period from 1992 to 2017 is shown in Fig. 1a. From 1992 to
2008, the treatment rate; biomass salmonids (tonnes) treated per bio-
mass salmonids (tonnes) produced, was rather stable, varying from 0.6
to 1.5 times per year (Fig. 1b). Since 2008, the biomass produced of
farmed salmon, rainbow trout and arctic char were lower than the
biomasses treated, implicating that the annual treatment ratio is above
one (Grave et al., 2004). In 2014, the ratio between produced and
treated biomass peaked with an annual treatment ratio of 5.7. From
2015, the treated biomass declined reaching an annual treatment ratio
below 1.0 in 2017.
3.2. Residues of veterinary drugs
From 2002 to 2017, more than 3000 pooled samples were examined
for residues of anti-sea lice agents (Supplement table 1). The analyses
include dichlorvos, azamethiphos, diflubenzuron, teflubenzuron, cy-
permethrin, deltamethrin or/and emamectin. During this period, re-
sidues of emamectin, cypermethrin, diflubenzuron and teflubenzuron
were detected, but no residues were detected at concentrations above
the EU maximum residue limit (European Commission, 2010) (Fig. 2).
However, the two highest measured levels of emamectin corresponded
to 94% and 34% of the MRL. The highest level detected of cypermethrin
was 30% of the MRL, whereas the highest concentration of di-
flubenzuron and teflubenzuron were 1% and 3% of the MRL, respec-
tively.
4. Discussion
Sea lice represent a major challenge for marine aquaculture. Here,
we assess the use of anti-sea lice drugs from 1992 to 2017 and the
presence of medical residues in farmed salmonids from 2002 to 2017.
Although a severe increase in the use of anti-sea lice agents during the
last two decades was observed, we did not detect residue levels above
the MRL in the fillet of the farmed fish.
4.1. Use of anti-sea lice agents in Norwegian farmed fish
While the amount of anti-sea lice agents used decreased in the end
of the 90s and remained low until 2009, the biomass treated were re-
latively stable from 1992 to 2008. The reason for this discrepancy is the
shift from therapeutics with low potency, like metrifonate, dichlorvos
and hydrogen peroxide towards more potent compounds like cyper-
methrin, deltamethrin and emamectin. Hence, the amount of active
compound used, but not the amount biomass treated is reduced in this
period. From 2008 to 2009, we observed a steep increase in the use of
anti-sea lice agents. However, the dosage of the different anti-sea lice
agents varies greatly and in 2009 treatment also included hydrogen
peroxide. Whereas 1 kg deltamethrin is used to treat 17 million kg fish,
1 kg hydrogen peroxide is used to treat only 33 kg fish. In order to
adjust for the differences in dosage for the various anti sea lice agents
the biomass fish treated were calculated using the prescription data.
Hence, use that are not in accordance with the prescription data will
therefore not be identified. Due to problems with resistance, off-label
use including increasing dosage level and use of combination treat-
ments of two or more therapeutics have been conducted (Jackson et al.,
2018). Such use will lead to an overestimation of the biomass treated.
The observed increase in both the amount of therapeutics used, and
biomass treated from 2009 and onwards, is most likely due to reduced
sensitivity or resistance to the therapeutics used. Reduced sensitivity or
resistance towards azamethiphos, the pyrethroids, emamectin and hy-
drogen peroxide is documented, but so far, no cases with confirmed
insensitivity towards teflubenzuron or diflubenzuron are reported
(Aaen et al., 2015). One major cause of the rapid spread of resistance
towards azamethiphos, the pyrethroids, emamectin and hydrogen per-
oxide may relate to the lack of available alternative treatments when
resistance emerged in 2008–2009. Hence, the fish health services used
the same compounds in combination or at escalating doses to attain the
required regulatory limit of 0.5 adult female lice per fish. When re-
sistance towards a drug is emerging, any application of the drug will
rapidly exaggerate the resistance situation. As this was a widespread
practice after 2008, the problems escalated, resulting in an increase in
doses and frequency of treatments, a dramatic increase in total use of
the different compounds is observed. An official annually monitoring of
resistance to anti-sea lice agents in salmon lice has been conducted
since 2013 (Helgesen et al., 2018). The observed decreased treatment
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ratio between 2014 and 2017, relate to the increased use of non-che-
mical approaches (Overton et al., 2018; Helgesen et al., 2018). In 2014,
various forms of mechanical treatment were performed 176 times. The
use of mechanical treatments increased the following years and reached
1665 in 2017 (Barentswatch, 2018). In addition, cleaner fish added to
the net pens has been used to reduce the number of sea lice in the farms.
The number of cleaner fish increased from 26 million in 2014 to 51
million in 2017 (Directorate of Fisheries, 2017).
Sea lice is also a major problem in other salmonid producing
countries. In Chile, the second largest producer of salmonids, data from
2007 to 2012 showed that the biomass of salmonids treated had been
higher than the slaughter volume for the hole period, in 2012 the
biomass of salmonids treated was more than nine times the slaughter
volume (Helgesen et al., 2014). In Scotland, treatment rate, calculated
as the number of treated sites divided by the number of occupied sites,
increased from approximately 1.88 treatments per year in 2005 to 3.39
treatments per year in 2011 (Murray, 2016). Data from the USA showed
that in Washington, with an annual production of around 5000 t, no
anti sea lice agents were used from 2012 to 2017. However, in Maine,
with an annual production of around 15,000 t, emamectin was used in
13 of 21 production cycles from 2014 to 2017, also hydrogen peroxide
was used for treatment, but no further anti sea lice agents were used
(Love et al., 2020).
4.2. Residues of veterinary drugs
Until 2006, no residues of anti-sea lice agents were detected in the
samples analyzed (Fig. 2). From 2006 and onwards residues of ema-
mectin have been found in samples each year. Residues of cypermethrin
was detected for the first time in 2010, since then it has been found
most years. Residues of diflubenzuron were detected in 2015 to 2017,
while residues of teflubenzuron was found in one sample in 2016. The
highest numbers of positive samples were detected in 2015 and 2016.
In 2015, residues of anti-sea lice agents were detected in 21 samples,
co-occurring with the highest registered use of anti-sea lice agents (in
kilograms). In 2016, the use (in kilograms) declined, and a steep de-
crease was registered in 2017, but a co-occurring decrease in number of
positive samples was not observed. Of note, however, emamectin re-
presented a high fraction of the positive samples in 2016 and 2017, and
the reduction in use of emamectin was not as pronounced as the re-
duction in total use. For diflubenzuron, the LOQ was lowered from
10 μg/kg to 1.0 μg/kg in 2015 (Supplement table 2). Since eight of the
ten detections of diflubenzuron were within the interval of 1.0 to 10 μg/
kg, introduction of this new LOQ could explain the increased detection
of diflubenzuron after 2015 (Supplement table 3). Moreover, results
from cypermethrin monitoring suggests a steady detection rate
throughout the years of analyses. However, the lowering of the LOQ for
cypermethrin from 10 μg/kg to 5.0 μg/kg in 2015 suggest a higher
detection rate of this compound before 2015 could be masked, since six
Table 2
Chemicals used against sea lice from 1992 to 2017.
Year Cypermethrin Deltamethrin Emamectin Pyrethrins Metrifonate Dichlorvos Azamethiphos Diflubenzuron Teflubenzuron Hydrogen peroxide
1992 1,946            3,115           
1993 1,779            2,470           7,10,000       
1994                32 1,227            1,147           389                    2,90,000       
1995                26 395              738                    3,40,000       
1996 23                                     9 161              606                    160                    610                     1,60,000       
1997 28                                   18 36                315                    361                    1,510                  20,000          
1998 3                      19                   182                    437                    1,334                  
1999 19                    11                   4                   14                      50                      231                     
2000 73                    23                   30                 12                      62                       
2001 69                    19                   12                 28                       
2002 62                    23                   20                 
2003 59                    16                   23                 
2004 55                    17                   32                 
2005 45                    16                   39                 
2006 49                    23                   60                 
2007 30                    29                   73                 
2008 32                    39                   81                 66                      
2009 88                    62                   41                 1,884                 1,413                 2,028                  3,08,000       
2010 107                   61                   22                 3,346                 1,839                 1,080                  30,71,000     
2011 48                    54                   105               2,437                 704                    26                       31,44,000     
2012 232                   121                 36                 4,059                 1,611                 751                     25,38,000     
2013 211                   136                 51                 3,037                 3,264                 1,704                  82,62,000     
2014 162                   158                 172               4,630                 5,016                 2,674                  3,15,77,000  
2015 85                    115                 259               3,904                 5,896                 2,509                  4,32,46,000  
2016 48                      43                     232                1,269                  4,824                  4,209                  2,65,97,000  
2017 8                        14                     128                204                     1,803                  293                      92,77,000      
Chemicals used against sea lice from 1992 to 2017 (kg active substance).
Data are presented by numbers and data bars. For each compound the databars are normalized to maximum use. Colors visualize different ranges of use, based on the
maximum use. Green:> 0–500; Yellow;> 0–10,000; red:> 0–50,000,000.
Source: Norwegian Institute of Public Health.
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out of nine samples, post 2015, were within the interval of 5 to 10 μg/
kg (Supplement table 3).
Data on residues of anti-sea lice agents in fish is scarce. However,
monitoring data from the EU (European Commission, 1996) shows that
in 2016, residues of emamectin above the MRL were detected in three
of 562 targeted samples analyzed (EFSA, 2018). While no residues of
anti-sea lice agents above the MRL were detected in 2017 (EFSA, 2019).
Data on results of residues above the LOQ but below the MRL were not
available. Violation data from EU, United States, Canada and Japan
from 2002 to 2009 shows that 3% of the drug violations in finfish in
Canada were caused by avermectins (Love et al., 2011). However, most
of the violations in both the EU, United States, Canada and Japan were
caused by compounds that are not authorized to use in the EU and
residues of antibiotics.
4.3. Food safety
Residues of emamectin, cypermethrin, diflubenzuron and te-
flubenzuron have been detected in the samples of fish, however, none of
the samples had residue levels above the MRL set by the EU. The most
commonly found anti-sea lice agent was emamectin. The highest level
measured was 94 μg/kg, and hence, emamectin was the anti-sea lice
agent that had residues closest to the MRL. In order to ensure consumer
safety, EU has determined an acceptable daily intake (ADI) value of
0.5 μg/kg body weight per day for emamectin (European Food Safety
Authority, 2012). For a person, with a body weight of 60 kg, con-
sumption of 200 g of salmon, with the maximum measured emamectin
level of 94 μg/g, would contribute to 63% of the ADI. During medica-
tion, anti-sea lice agents can be distributed around the farms, and re-
sidues may be found in the wild fauna (Wang et al., 2019; Samuelsen
et al., 2015). In addition, emamectin is also approved as a pesticide.
Therefore, it cannot be excluded that intake of farmed fish, with ema-
mectin level close to the MRL, together with other food sources con-
taining emamectin residues could lead to an exposure that will exceed
the ADI. However, the ADI is based on chronic exposure, therefore, it
will be more appropriate to compare the intake with the acute reference
dose (ARfD). The European Food Safety Authority (EFSA) has estab-
lished an ARfD for emamectin of 10 μg/kg bw (European Food Safety
Authority, 2012). An intake of 200 g salmon, with emamectin level
close to the MRL, will only contribute to 3% of the ARfD.
Since all samples represent fish ready for human consumption, fish












































Fig. 1. The biomass of salmonids treated with different anti-sea lice agents from 1992 to 2017. A. Biomass of salmonids treated with anti-sea lice agents. B. Treatment
ratio of anti-sea lice agents. Black line represents biomass treated (tonnes) per biomass produced (tonnes). Dotted line represents a treatment ratio of one; the amount
salmonids treated is equal to the amount salmonids produced.
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slaughtering. The withdrawal period is established to ensure that the
food do not contain residues of veterinary drugs in excess of the es-
tablished MRL. The absence of data above the corresponding MRL va-
lues indicates that the established withdrawal periods are appropriate.
The MRL set by the EU is established based on the knowledge
available at the time being. New data can lead to a review of the MRL.
For diflubenzuron, concern has been raised regarding p-chloroaniline, a
possible impurity and metabolite of diflubenzuron. After a re-evalua-
tion (Committee for Medicinal Products for Veterinary Use, 2018), the
MRL for diflubenzuron will be reduced from 1000 μg/g to 10 μg/g
(European Commission, 2019). From 2002 to 2017, residues of di-
flubenzuron above 10 μg/g were detected in two pooled samples. An
increase in withdrawal time should be considered to avoid residue
levels above the MRL.
5. Conclusion
This study presents the use of anti-sea lice agents in Norwegian
aquaculture from 1992 to 2017, and the presence of residues of these
agents in farmed fish from 2002 to 2017. The amount of anti-sea lice
agents used increased from 1992 to 2015 but decreased in 2016 and
2017. All samples studied demonstrated compliance to EU regulations.
Based on the established MRLs, the use of veterinary drugs against sea

























































































































































































Fig. 2. The number of samples, and the level of residues of anti-sea lice agents detected in salmonids from 2002 to 2017. Colors visualizes percentage of MRL. Light
grey:< LOQ, grey:> LOQ – 50% of MRL, black:> 50% of MRL. A. Emamectin. B. Cypermethrin. C Diflubenzuron. D. Teflubenzuron.
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